Announcements Trials
Browse Landscape

Phase

Phase 1 4Phase 1/2 2Phase EARLY_PHASE1 1Phase 2 1

Status

Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 4Thoracic 2Gastrointestinal 2Dermatologic 2Head & Neck 1Gynecologic 1Genitourinary 1Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 174Neoplasm Metastasis 139Neoplasms 133Leukemia, Myeloid, Acute 127Colorectal Neoplasms 126Breast Neoplasms 113Melanoma 88Ovarian Neoplasms 87Prostatic Neoplasms 86Recurrence 84Multiple Myeloma 79Pancreatic Neoplasms 74Squamous Cell Carcinoma of Head and Neck 72Glioblastoma 71Lung Neoplasms 70Lymphoma, Non-Hodgkin 62Myelodysplastic Syndromes 60Triple Negative Breast Neoplasms 56Stomach Neoplasms 52Glioma 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 49Endometrial Neoplasms 47Carcinoma, Renal Cell 47Small Cell Lung Carcinoma 46Lymphoma, Large B-Cell, Diffuse 44Brain Neoplasms 43Carcinoma, Hepatocellular 41Sarcoma 39Advanced Solid Tumors 39Lymphoma, Follicular 38

Interventions

Cyclophosphamide 2pembrolizumab 1fludarabine phosphate 1fludarabine 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × Liposarcoma, Myxoid × 90 days × Clear all
NCT03132922 2026-06-04

MAGE-A4ᶜ¹º³²T for Multi-Tumor

USWM, LLC (dba US WorldMeds)

Phase 1 Active not recruiting
71 enrolled 20 charts
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckSarcomaThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Sarcoma, Stomach Neoplasms, Sarcoma, Synovial, Liposarcoma, Myxoid

NCT05492682 2026-05-12

START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer

Valo Therapeutics Oy

Phase 1 Recruiting
15 enrolled
BreastDermatologicGastrointestinalSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Sarcoma, Osteosarcoma, Sarcoma, Synovial, Colorectal Neoplasms, Liposarcoma, Myxoid, Triple Negative Breast Neoplasms

NCT06414434 2026-04-30

BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma

Dana-Farber Cancer Institute

Phase 1 Active not recruiting
24 enrolled
Sarcoma

Liposarcoma, Liposarcoma, Myxoid

NCT06083883 2026-04-16

Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1

M.D. Anderson Cancer Center

Phase 1 Recruiting
44 enrolled
Sarcoma

Sarcoma, Synovial, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡